My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 158

    1.

    Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

    Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH.

    Ann Intern Med. 1995 Dec 15;123(12):897-903.PMID: 7486483 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

    Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O.

    J Hepatol. 1996 Nov;25(5):591-8.PMID: 8938532 [PubMed - indexed for MEDLINE]Related articles

    3.

    Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.

    Tong MJ, Hwang SJ, Lefkowitz M, Lee SD, Co RL, Conrad A, Schmid P, Lo KJ.

    J Gastroenterol Hepatol. 1994 Nov-Dec;9(6):587-91.PMID: 7865717 [PubMed - indexed for MEDLINE]Related articles

    4.

    Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.

    N Engl J Med. 1998 Nov 19;339(21):1493-9.PMID: 9819447 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

    Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C.

    Gut. 2003 Feb;52(2):283-7.PMID: 12524414 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis C in Chinese patients: a randomized, placebo-controlled trial.

    Han Q, Liu Z, Kang W, Li H, Zhang L, Zhang N.

    Dig Dis Sci. 2008 Aug;53(8):2238-45. Epub 2007 Dec 13.PMID: 18080763 [PubMed - indexed for MEDLINE]Related articles

    7.

    Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.

    Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ.

    Hepatology. 2003 Jul;38(1):66-74.PMID: 12829988 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study]

    Pár A, Roth E, Miseta A, Hegedüs G, Pár G, Hunyady B, Vincze A.

    Orv Hetil. 2009 Jan 11;150(2):73-9. Hungarian. PMID: 19103558 [PubMed - indexed for MEDLINE]Related articles

    9.

    Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.

    Yamada G, Iino S, Okuno T, Omata M, Kiyosawa K, Kumada H, Hayashi N, Sakai T.

    Clin Drug Investig. 2008;28(1):9-16. Erratum in: Clin Drug Investig. 2008;28(4):210. PMID: 18081356 [PubMed - indexed for MEDLINE]Related articles

    10.

    Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group.

    Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, Conjeevaram HS, Sallie R, Di Bisceglie AM.

    Ann Intern Med. 1995 Sep 1;123(5):330-7.PMID: 7542854 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C.

    Hepatology. 1997 Aug;26(2):500-4.PMID: 9252166 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prolonged therapy of chronic hepatitis C with ribavirin.

    Hoofnagle JH, Lau D, Conjeevaram H, Kleiner D, Di Bisceglie AM.

    J Viral Hepat. 1996 Sep;3(5):247-52.PMID: 8914004 [PubMed - indexed for MEDLINE]Related articles

    13.

    Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.

    Niederau C, Strohmeyer G, Heintges T, Peter K, Göpfert E.

    Hepatogastroenterology. 1998 May-Jun;45(21):797-804.PMID: 9684137 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

    Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S.

    Ann Intern Med. 1997 Nov 15;127(10):875-81.PMID: 9382365 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

    Bodenheimer HC Jr, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seeff LB.

    Hepatology. 1997 Aug;26(2):473-7.PMID: 9252161 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.

    Bonkovsky HL, Stefancyk D, McNeal K, Banner BF, Liu Q, Zucker GM, Israel J, Stagias J, Colker J.

    Dig Dis Sci. 2001 Oct;46(10):2051-9.PMID: 11680575 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.

    N Engl J Med. 1998 Nov 19;339(21):1485-92.PMID: 9819446 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection.

    Ljubuncic P, Konikoff FM, Blendis LM, Bomzon A.

    Hepatogastroenterology. 2005 Jul-Aug;52(64):1191-6.PMID: 16001659 [PubMed - indexed for MEDLINE]Related articles

    19.

    Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

    Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH.

    Ann Intern Med. 1991 Nov 1;115(9):700-4.PMID: 1656828 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.

    Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G.

    Hepatology. 1998 Aug;28(2):341-6.PMID: 9695995 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity